Evidence map›Paper›PMID 36203605›Full record

ArticleFrontiers in immunology2022

Immunological risk factors for sepsis-associated delirium and mortality in ICU patients.

Wen Lei, Zhiyao Ren, Jun Su, Xinglong Zheng, Lijuan Gao, Yudai Xu, Jieping Deng, Chanchan Xiao, Shuai Sheng, Yu Cheng and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Disulfidptosis modification patterns are involved in the immune microenvironment regulation of septic acute respiratory distress syndrome.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Wen LeiDepartment of Microbiology and Immunology, School of Medicine, Jinan University, Guangzhou, China.
Zhiyao RenGuangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Jinan University, Guangzhou, China.
Jun SuGuangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Jinan University, Guangzhou, China.
Xinglong ZhengGuangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Jinan University, Guangzhou, China.
Lijuan GaoDepartment of Microbiology and Immunology, School of Medicine, Jinan University, Guangzhou, China.
Yudai XuDepartment of Microbiology and Immunology, School of Medicine, Jinan University, Guangzhou, China.
Jieping DengDepartment of Microbiology and Immunology, School of Medicine, Jinan University, Guangzhou, China.
Chanchan XiaoDepartment of Microbiology and Immunology, School of Medicine, Jinan University, Guangzhou, China.
Shuai ShengGuangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Jinan University, Guangzhou, China.
Yu ChengDepartment of Microbiology and Immunology, School of Medicine, Jinan University, Guangzhou, China.
Tianshun MaDepartment of Microbiology and Immunology, School of Medicine, Jinan University, Guangzhou, China.
Yu LiuGuangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Jinan University, Guangzhou, China.
Pengcheng WangDepartment of Microbiology and Immunology, School of Medicine, Jinan University, Guangzhou, China.
Oscar Junhong LuoGuangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Jinan University, Guangzhou, China.
Guobing ChenDepartment of Microbiology and Immunology, School of Medicine, Jinan University, Guangzhou, China.
Zhigang WangGuangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Jinan University, Guangzhou, China.
Jinan University · CNFirst Affiliated Hospital of Jinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A major challenge in intervention of critical patients, especially sepsis-associated delirium (SAD) intervention, is the lack of predictive risk factors. As sepsis and SAD are heavily entangled with inflammatory and immunological processes, to identify the risk factors of SAD and mortality in the intensive care unit (ICU) and determine the underlying molecular mechanisms, the peripheral immune profiles of patients in the ICU were characterized. Methods: This study contains a cohort of 52 critical patients who were admitted to the ICU of the First Affiliated Hospital of Jinan University. Comorbidity, including sepsis and SAD, of this cohort was diagnosed and recorded. Furthermore, peripheral blood samples were collected on days 1, 3, and 5 of admission for peripheral immune profiling with blood routine examination, flow cytometry, ELISA, RNA-seq, and qPCR. Results: The patients with SAD had higher mortality during ICU admission and within 28 days of discharge. Compared with survivors, nonsurvivors had higher neutrophilic granulocyte percentage, higher CRP concentration, lower monocyte count, lower monocyte percentage, lower C3 complement level, higher CD14 Conclusions: Nonsurvival critical patients have a distinct immune profile when compared with survival patients. CD14

Indexed as

SepsisSepsis-Associated EncephalopathyComplement C3HumansIntensive Care UnitsInterleukin-6Risk FactorsTumor Necrosis Factor-alphaComplement C3Interleukin-6Tumor Necrosis Factor-alphagene expressionICUimmune profilemonocytemortalitysepsis-associated delirium

Identifiers

PMID36203605
PMCPMC9531264
OpenAlexW4296401000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.